Cangrelor tetrasodium and Infliximab Injection

• Generic Name: cangrelor
• Dosage Forms: n.a.
• Other Brand Names: Kengreal

Used as an adjunct to PCI to reduce the risk of periprocedural MI, repeat coronary revascularization, and stent thrombosis in patients who have not been treated with a P2Y12-receptor antagonist and are not being given a glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitor.

Dual-drug antiplatelet therapy with a P2Y12-receptor antagonist and aspirin is part of the current standard of care in patients with acute coronary syndromes (ACS).

Potential advantages of cangrelor include rapid onset and offset of effect and less interindividual variability in antiplatelet effect (i.e., compared with clopidogrel).

Precise role of cangrelor in the management of ACS remains to be established.

• Generic Name: infliximab
• Dosage Forms: n.a.
• Other Brand Names: Inflectra, Remicade, Renflexis

• It is used with methotrexate to prevent more problems in patients with moderate to very bad rheumatoid arthritis.
• It is used to treat Crohn's disease.
• It is used to treat psoriatic arthritis.
• It is used to treat plaque psoriasis.
• It is used to treat ankylosing spondylitis.
• It is used to treat ulcerative colitis.
• It may be given to you for other reasons. Talk with the doctor.